image by: HWN

HWN Suggests

A little journey...

Basically, last year was a hard one. The hardest we’ve had. And it’s been quite a road to get to where we are now, today. But we did get here, and I want to tell you about it... So, if you don't know, Emma was diagnosed with a rare genetic disorder, called Fanconi anemia, and it more or less breaks down into four main phases: Healthy Phase (often early childhood), Life-threatening Blood Issues Phase (Often mid-childhood), Return to Health “Bucket list" Phase (often late-childhood/teens), Cancer/life expectancy Phase. (20-30 years old).

Emma went through Phase 1 and 2. So, Phase 3 was our next phase. The one we starting calling the Bucket List one. And when a person enters this phase,…

read full article

Featured

 Modern management of Fanconi anemia

While several nontransplant treatments are currently under evaluation, hematopoietic stem cell transplantation (HSCT) remains the only therapeutic option for bone marrow failure (BMF). Although HSCT outcomes in patients with FA have remarkably improved over the past 20 years, in addition to the mortality intrinsic to the procedure, HSCT increases the risk and accelerates the appearance of late malignancies

 The Made-to-Order Savior

Many Fanconi parents have conceived second children to save their first, hoping that luck would bring them a match.

Articles of Interest

BRCA2 and Fanconi Anemia

Fanconi Anemia is a rare inherited disorder that can affect children. Children with FA have bone marrow that doesn’t produce enough blood cells. Several genes have been associated with FA, including the BRCA2 gene. A child must inherit two abnormal BRCA2 mutations—one from each parent—to develop FA.

An update on Fanconi anemia: Clinical, cytogenetic and molecular approaches

Although early diagnosis does not currently allow for improved cure rates for this condition, it does enable healthcare professionals to perform a specific systematic follow‑up and, if indicated, a bone marrow transplantation that improves the mobility and mortality of affected individuals.

Cameron’s Story: Surviving Fanconi Anemia

What is it like to watch your child grow up all the while knowing she will one day need a life-saving treatment? That was the situation 13-year-old Cameron and her family faced for years. Diagnosed with Fanconi anemia (FA) at just 10-days-old, Cameron and her family spent volumes of time researching the disease, investigating treatment options and ultimately, preparing for the day that Cameron would finally need a bone marrow transplant to save her life.

Could editing the DNA of embryos with CRISPR help save people who are already alive?

But making an embryo that’s both healthy and a suitable donor “match” for the older sibling is an exercise in long odds. It’s theoretically possible that altering an embryo’s DNA with the genome-editor CRISPR could improve the process.

Fanconi Anaemia and Stem Cells

Fanconi anaemia results in bone marrow failure, a very serious condition whereby the bone marrow makes insufficient blood cells to allow the body to function properly. FA can also cause the bone marrow to make many defective blood cells which can result in leukaemia, a type of blood cancer. In addition to anaemia and bone marrow failure, there are a series of birth defects associated with Fanconi anaemia. These can include congenital heart defects, kidney problems or even a missing kidney, skeletal defects and congenial hearing loss to name but a few.

Fanconi Anemia, A Simple Guide To The Condition, Diagnosis, Treatment And...

The symptoms of FA can be treated but there is no cure for FA.

Fisher, London team up vs. Fanconi anemia

Virginia coach Mike London and Florida State coach Jimbo Fisher are taking their roles of football coaches to a whole new level and joining forces as fathers before their game this weekend to help raise awareness for Fanconi anemia, a rare genetic disorder that causes bone marrow failure and has affected each of their children.

Parents create baby to save sister

Fanconi anaemia is universally fatal without a transplant, but Molly is now said to have a 85-90% chance of recovering. Their parents, Lisa and Jack Nash, had a 25% chance of passing on the Fanconi gene to any new child and were afraid of conceiving normally. So they made use of a new technique called pre-implantation genetic diagnosis.

Those designer babies everyone is freaking out about – it’s not likely to happen

When Adam Nash was still an embryo, living in a dish in the lab, scientists tested his DNA to make sure it was free of Fanconi anemia, the rare inherited blood disease from which his sister Molly suffered. They also checked his DNA for a marker that would reveal whether he shared the same tissue type. Molly needed a donor match for stem cell therapy, and her parents were determined to find one.

What is FA?

Fanconi anemia (FA) is a rare genetic disease caused by mutations in any of the known 23 genes (including genes such as BRCA1 and BRCA2) that play a role in the FA DNA repair pathway. Dysfunctional DNA repair in all cells of the body means that people living with FA have a very high risk of developing bone marrow failure and cancer in addition to many other systemic issues. FA affects both males and females equally and is found in all ethnic groups.

“I care about rare.” Rare disease research brings leading-edge care to patients with Fanconi anemia

Two siblings, one diagnosis, and a difficult journey with a rare disease. The Becerra family shares their Fanconi anemia story in honor of Rare Disease Day.

Resources

Fanconi Anemia Research Fund

Our mission is to find effective treatments and a cure for Fanconi anemia and to provide education and support services to affected families worldwide.

Our Little Taste of Heaven

Hello! Many of you know us from our Facebook page, but for those that are new, we're Tyler & Teresa. We have five children, one of whom has a life-threatening disease that causes bone marrow failure and different types of cancers.

Aplastic Anaemia Trust

Fanconi anaemia is rare and occurs in 1 in 160,000 individuals worldwide. This condition is more common among people of Ashkenazi Jewish descent, the Roma population of Spain, and black South Africans.

StatPearls

Fanconi anemia is a rare genetic disorder, involving all three blood cell lines. It is the most common cause of inherited bone marrow failure characterized by pancytopenia.